A phase IIa clinical trial of ANAVEX 2-73 and ANAVEX PLUS (combination of ANAVEX 2-73 and donepezil) for Alzheimer's disease
Latest Information Update: 14 Jan 2019
At a glance
- Drugs ANAVEX-2-73/donepezil (Primary) ; Blarcamesine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
Most Recent Events
- 14 Jan 2019 New trial record